Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01586000 · ClinicalTrials.gov registry record · Phase 2
A Dose-finding Study to Evaluate the Effect of a Contraceptive Vaginal Ring, Releasing Nestorone® and Estradiol, on Cycle Control, Ovulation Inhibition, and Pharmacokinetics in Normal Cycling Women
A Phase 2 study of Suppression of Ovulation, sponsored by Kimberly Myer.
- Completed
- Registry status
- Phase 2
- Development phase
- 197
- Enrollment target
- 8
- Study locations
NCT01586000 is a Phase 2 study of Suppression of Ovulation that has completed, run by Kimberly Myer. The registered enrollment target is 197 participants. The trial reports 8 study locations across 6 states.
The verdict
NCT01586000, a Phase 2 study of Suppression of Ovulation, has completed, sponsored by Kimberly Myer.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 197 participants
- Enrollment target
- 8
- Study locations
Study Summary
This clinical trial is an experimental research study using a potential new form of birth control. Clinical trials include people who volunteer to take part in a study. Take your time to decide if you want to be part of this experimental research study. If you want to know more about this study first, ask the study doctor or study site staff. The investigators can also give you the study information written for doctors and clinic staff.
Conditions Studied
Interventions
- DRUG 10 µg/day E2 with NES 200® µg/day
- DRUG 20 µg/day E2 with NES 200® µg/day
- DRUG 40 µg/day E2 with NES 200® µg/day
Study Locations (8)
New York
- NYU School of Medicine - New York
- Columbia University - New York
Pennsylvania
- University of Pennsylvania School of Medicine - Philadelphia
- Univeristy of Pittsburgh School of Medicine - Pittsburgh
Maryland
- Johns Hopkins School of Medicine - Baltimore
Ohio
- University of Cincinnati - Cincinnati
Oregon
- Oregon Health & Science University - Portland
Virginia
- Eastern Virginia Medical School - Norfolk
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 197 participants |
| Start Date | 2012-03 |
| Est. Completion | 2015-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01586000
The ClinicalTrials.gov registry entry for NCT01586000 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 197 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kimberly Myer, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Suppression of Ovulation appearing as the primary indexed condition, and to 3 interventions - of which 10 µg/day E2 with NES 200® µg/day is the first listed.
NCT01586000 reports 8 study locations spanning 6 distinct geographic areas - top geographies include New York, Pennsylvania, Maryland.
Frequently Asked Questions
What is clinical trial NCT01586000 about?
NCT01586000 is a clinical study titled "A Dose-finding Study to Evaluate the Effect of a Contraceptive Vaginal Ring, Releasing Nestorone® and Estradiol, on Cycle Control, Ovulation Inhibition, and Pharmacokinetics in Normal Cycling Women". This clinical trial is an experimental research study using a potential new form of birth control. Clinical trials include people who volunteer to take part in a study. Take your time to decide if you want to be part of this experimental research study. If you want to know more about this study firs...
What is the current status of trial NCT01586000?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 197 participants. The study started on 2012-03. Estimated completion is 2015-05.
What conditions does trial NCT01586000 study?
This clinical trial studies the following conditions: Suppression of Ovulation.
What interventions are being tested in trial NCT01586000?
The interventions under investigation include: 10 µg/day E2 with NES 200® µg/day (DRUG), 20 µg/day E2 with NES 200® µg/day (DRUG), 40 µg/day E2 with NES 200® µg/day (DRUG).
Who is sponsoring clinical trial NCT01586000?
This trial is sponsored by Kimberly Myer, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01586000 being conducted?
This trial has 8 study locations across Maryland, New York, Ohio, Oregon, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.